-+ 0.00%
-+ 0.00%
-+ 0.00%

Stock price material preview (4th) Astellas revises upward net profit by 20% this fiscal year due to growth in major products such as anticancer drugs.

NIKKEI QUICK·11/04/2026 07:29:09

Please log in to view news